Biotest Aktiengesellschaft Price Patterns

BIESFDelisted Stock  USD 32.00  0.00  0.00%   
As of 12th of February 2026 the relative strength index (rsi) of Biotest Aktiengesellscha's share price is below 20 suggesting that the pink sheet is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards.

Momentum 0

 Sell Peaked

 
Oversold
 
Overbought
The successful prediction of Biotest Aktiengesellscha's future price could yield a significant profit. Please, note that this module is not intended to be used solely to calculate an intrinsic value of Biotest Aktiengesellscha and does not consider all of the tangible or intangible factors available from Biotest Aktiengesellscha's fundamental data. We analyze noise-free headlines and recent hype associated with Biotest Aktiengesellschaft, which may create opportunities for some arbitrage if properly timed.
Using Biotest Aktiengesellscha hype-based prediction, you can estimate the value of Biotest Aktiengesellschaft from the perspective of Biotest Aktiengesellscha response to recently generated media hype and the effects of current headlines on its competitors.
The fear of missing out, i.e., FOMO, can cause potential investors in Biotest Aktiengesellscha to buy its pink sheet at a price that has no basis in reality. In that case, they are not buying Biotest because the equity is a good investment, but because they need to do something to avoid the feeling of missing out. On the other hand, investors will often sell pink sheets at prices well below their value during bear markets because they need to stop feeling the pain of losing money.

Biotest Aktiengesellscha after-hype prediction price

    
  USD 32.0  
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as pink sheet price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
  
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Biotest Aktiengesellscha's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Intrinsic
Valuation
LowRealHigh
27.2027.2035.20
Details
Naive
Forecast
LowNextHigh
32.0032.0032.00
Details
Bollinger
Band Projection (param)
LowerMiddle BandUpper
32.0032.0032.00
Details

Biotest Aktiengesellscha After-Hype Price Density Analysis

As far as predicting the price of Biotest Aktiengesellscha at your current risk attitude, this probability distribution graph shows the chance that the prediction will fall between or within a specific range. We use this chart to confirm that your returns on investing in Biotest Aktiengesellscha or, for that matter, your successful expectations of its future price, cannot be replicated consistently. Please note, a large amount of money has been lost over the years by many investors who confused the symmetrical distributions of Pink Sheet prices, such as prices of Biotest Aktiengesellscha, with the unreliable approximations that try to describe financial returns.
   Next price density   
       Expected price to next headline  

Biotest Aktiengesellscha Estimiated After-Hype Price Volatility

In the context of predicting Biotest Aktiengesellscha's pink sheet value on the day after the next significant headline, we show statistically significant boundaries of downside and upside scenarios based on Biotest Aktiengesellscha's historical news coverage. Biotest Aktiengesellscha's after-hype downside and upside margins for the prediction period are 32.00 and 32.00, respectively. We have considered Biotest Aktiengesellscha's daily market price in relation to the headlines to evaluate this method's predictive performance. Remember, however, there is no scientific proof or empirical evidence that news-based prediction models compare with traditional linear, nonlinear models or artificial intelligence models to provide accurate predictions consistently.
Current Value
32.00
32.00
After-hype Price
32.00
Upside
Biotest Aktiengesellscha is very steady at this time. Analysis and calculation of next after-hype price of Biotest Aktiengesellscha is based on 3 months time horizon.

Biotest Aktiengesellscha Pink Sheet Price Outlook Analysis

Have you ever been surprised when a price of a Company such as Biotest Aktiengesellscha is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Biotest Aktiengesellscha backward and forwards among themselves. Have you ever observed a lot of a particular company's price movement is driven by press releases or news about the company that has nothing to do with actual earnings? Usually, hype to individual companies acts as price momentum. If not enough favorable publicity is forthcoming, the Pink Sheet price eventually runs out of speed. So, the rule of thumb here is that as long as this news hype has nothing to do with immediate earnings, you should pay more attention to it. If you see this tendency with Biotest Aktiengesellscha, there might be something going there, and it might present an excellent short sale opportunity.
Expected ReturnPeriod VolatilityHype ElasticityRelated ElasticityNews DensityRelated DensityExpected Hype
 0.00  
0.00
 0.00  
 0.00  
0 Events / Month
0 Events / Month
In 5 to 10 days
Latest traded priceExpected after-news pricePotential return on next major newsAverage after-hype volatility
32.00
32.00
0.00 
0.00  
Notes

Biotest Aktiengesellscha Hype Timeline

Biotest Aktiengesellscha is currently traded for 32.00. The entity stock is not elastic to its hype. The average elasticity to hype of competition is 0.0. Biotest is projected not to react to the next headline, with the price staying at about the same level, and average media hype impact volatility is insignificant. The immediate return on the next news is projected to be very small, whereas the daily expected return is currently at 0.0%. %. The volatility of related hype on Biotest Aktiengesellscha is about 0.0%, with the expected price after the next announcement by competition of 32.00. The book value of the company was currently reported as 8.9. The company recorded a loss per share of 1.45. Biotest Aktiengesellscha last dividend was issued on the 6th of May 2022. The entity had 3:1 split on the 15th of July 2015. Assuming the 90 days horizon the next projected press release will be in 5 to 10 days.
Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.

Biotest Aktiengesellscha Related Hype Analysis

Having access to credible news sources related to Biotest Aktiengesellscha's direct competition is more important than ever and may enhance your ability to predict Biotest Aktiengesellscha's future price movements. Getting to know how Biotest Aktiengesellscha's peers react to changing market sentiment, related social signals, and mainstream news is a great way to find investing opportunities and time the market. The summary table below summarizes the essential lagging indicators that can help you analyze how Biotest Aktiengesellscha may potentially react to the hype associated with one of its peers.
Hype
Elasticity
News
Density
Semi
Deviation
Information
Ratio
Potential
Upside
Value
At Risk
Maximum
Drawdown
MITPFMithra Pharmaceuticals SA 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
NPRRFNipro Corp 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
KARBFKaro Pharma AB 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
DWRKFDrgerwerk AG Co 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
CMPVFCompuGroup Medical SE 0.00 0 per month 0.00 (0.04) 0.00  0.00  8.57 
CKDXFOpthea 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
BITGFBiotage AB 0.00 0 per month 0.00  0.13  2.91  0.00  31.10 
CMPUYCompuGroup Medical SE 0.00 0 per month 0.00 (0.08) 0.00  0.00  3.66 
MPSYFMorphoSys AG 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 
TBGNFOxurion NV 0.00 0 per month 0.00  0.00  0.00  0.00  0.00 

Biotest Aktiengesellscha Additional Predictive Modules

Most predictive techniques to examine Biotest price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for Biotest using various technical indicators. When you analyze Biotest charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.

About Biotest Aktiengesellscha Predictive Indicators

The successful prediction of Biotest Aktiengesellscha stock price could yield a significant profit to investors. But is it possible? The efficient-market hypothesis suggests that all published stock prices of traded companies, such as Biotest Aktiengesellschaft, already reflect all publicly available information. This academic statement is a fundamental principle of many financial and investing theories used today. However, the typical investor usually disagrees with a 'textbook' version of this hypothesis and continually tries to find mispriced stocks to increase returns. We use internally-developed statistical techniques to arrive at the intrinsic value of Biotest Aktiengesellscha based on analysis of Biotest Aktiengesellscha hews, social hype, general headline patterns, and widely used predictive technical indicators.
We also calculate exposure to Biotest Aktiengesellscha's market risk, different technical and fundamental indicators, relevant financial multiples and ratios, and then comparing them to Biotest Aktiengesellscha's related companies.

Currently Active Assets on Macroaxis

Check out Trending Equities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in producer price index.
You can also try the Bonds Directory module to find actively traded corporate debentures issued by US companies.

Other Consideration for investing in Biotest Pink Sheet

If you are still planning to invest in Biotest Aktiengesellscha check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Biotest Aktiengesellscha's history and understand the potential risks before investing.
Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Correlation Analysis
Reduce portfolio risk simply by holding instruments which are not perfectly correlated
USA ETFs
Find actively traded Exchange Traded Funds (ETF) in USA